Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
Epigenomics AG (OJ:ECX) Epigenomics AG / Voting rights: Correction Release of a Voting Rights Notification (§ 21 para. 1 WpHG) released on 11 September 2008 in Accordance with § 26, para. 1 WpHG (German Securities Trading Act) with the Aim of an Europe-wide Distribution Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
Issuer:
Epigenomics AG - ISIN DE000A0BVT96 - Kleine Präsidentenstr. 1 10178 Berlin Deutschland
Corrected Voting Rights Notification:
In correction of the voting rights notification dated 10 September 2008 and released by Epigenomics AG on 11 September 2008, Federated Investors Inc., Pittsburgh, PA, USA on 18 September 2008 made the following corrected notification in the name and on behalf of Federated Equity Management Company of Pennsylvania, Pittsburgh, PA, USA pursuant to § 21 para. 1 WpHG in connection with § 22 para. 1 sent. 1 no. 6 WpHG regarding the holding of voting rights held in Epigenomics AG:
On 8 September 2008 Federated Equity Management Company of Pennsylvania exceeded the 20 per cent threshold of § 21 para. 1 WpHG and held at this date 20.12 per cent of the voting rights (5,375,319 voting rights) in Epigenomics AG.
All 20.12 per cent of the voting rights (5,375,319 voting rights) are attributed to Federated Equity Management Company of Pennsylvania pursuant to § 22 para. 1 sent. 1 no. 6 WpHG. Some of the voting rights are attributed to Federated Equity Management Company of Pennsylvania by Federated Kaufmann Fund which holds directly 3 per cent or more of the voting rights in Epigenomics AG.
Federated Investors Inc. is the parent company of F II Holdings Inc., which in turn is the parent company of Federated Equity Management Company of Pennsylvania. Federated Equity Management Company of Pennsylvania, an investment adviser registered in the United States under the Investment Company Act of 1940, acts as Investment Adviser to the Federated Kaufmann Fund and Federated Kaufmann Fund II, both Massachusetts Business Trusts and Investment Companies, as that term is defined under the Investment Company Act 1940, as amended.
Date of release: 19 September 2008
Epigenomics AG The Executive Board
Contact: Epigenomics AG Dr. Achim Plum Sr. Vice President Corporate Development Tel.: +49 (0)30 24345 368 Fax: +49 (0)30 24345 555 Email: achim.plum@epigenomics.com
--- End of Message ---
Epigenomics AG Kleine Präsidentenstr.1 Berlin Germany
WKN: A0BVT9; ISIN: DE000A0BVT96; Index: CDAX, Prime All Share, TECH All Share; Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart;
